1. Hooker AB, de Leeuw RA, Emanuel MH, Emanuel MH, Mijatovic V, Brolmann HAM, Huirne JAF. The link between intrauterine adhesions and impaired reproductive performance: a systematic review of the literature. BMC Pregnancy Childbirth 2022; 22: 837.
2.
March CM. Asherman’s syndrome. Semin Reprod Med 2011; 29: 83-94.
3.
Yu X, Yuhan L, Dongmei S, Enlan X, Tinchiu L. The incidence of post-operative adhesion following transection of uterine septum: a cohort study comparing three different adjuvant therapies. Eur J Obstet Gynecol Reprod Biol 2016; 201: 61-64.
4.
Dreisler E, Kjer JJ. Asherman’s syndrome: current perspectives on diagnosis and management. Int J Womens Health 2019; 11: 191-198.
5.
Gharibeh N, Aghebati-Maleki L, Madani J, Pourakbari R, Yousefi M, Heris JA. Cell-based therapy in thin endometrium and Asherman syndrome. Stem Cell Res Ther 2022; 13: 33.
6.
Chen Y, Wang Y, Zhao Y, Zhang C. Clinical efficacy of hysteroscopic adhesiolysis combined with periodic balloon dilation for intrauterine adhesion in IVF treatment. Front Endocrinol (Lausanne) 2023; 14: 1236447.
7.
Leung RK, Lin Y, Liu Y. Recent advances in understandings towards pathogenesis and treatment for intrauterine adhesion and disruptive insights from single-cell analysis. Reprod Sci 2021; 28: 1812-1826.
8.
Guangwei W, Ling M, Qing Y, Yue Y, Yanqiu Y, Silei C, et al. Comparison of the efficacy of autologous platelet gel and medical chitosan in the prevention of recurrence of intrauterine adhesions after transcervical resection of adhesion: a prospective, randomized, controlled trial. Arch Gynecol Obstet 2023; 308: 1369-1378.
9.
Wang Y, Zhao Y, Ge Y, Cen J, Liao Y, Xu G. Reproductive outcomes and reproductive tract microbiota shift in women with moderate-to-severe intrauterine adhesions following 30-day post-hysteroscopic placement of balloon stents or intrauterine contraceptive devices: a randomized controlled trial. EClinicalMedicine 2022; 43: 101200.
10.
Yang L, Ma N, Song D, Huang X, Zhou Q, Guo Y, et al. The effect of estrogen in the prevention of adhesion reformation after hysteroscopic adhesiolysis: a prospective randomized control trial. J Minimall Inv Gynecol 2022; 29: 871-878.
11.
Xiong Q, Zhang T, Su S. A network meta-analysis of efficacy of different interventions in the prevention of postoperative intrauterine adhesions. Clin Transl Sci 2020; 13: 372-380.
12.
Vitale SG, Riemma G, Carugno J, Perez-Medina T, Pacheco LA, Haimovich S, et al. Postsurgical barrier strategies to avoid the recurrence of intrauterine adhesion formation after hysteroscopic adhesiolysis: a network meta-analysis of randomized controlled trials. Am J Obstet Gynecol 2022; 226: 487-498.e8.
13.
Khan Z, Goldberg JM. Hysteroscopic management of Asherman’s syndrome. J Minim Invasive Gynecol 2018; 25: 218-228.
14.
Mansouri-Kivaj N, Nazari A, Esfandiari F, Shekari F, Ghaffari M, Pakzad M, et al. Homogenous subpopulation of human mesenchymal stem cells and their extracellular vesicles restore function of endometrium in an experimental rat model of Asherman syndrome. Stem Cell Res Ther 2023; 14: 61.
15.
Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev 2016; 5: 210.
16.
Ma LL, Wang YY, Yang ZH, Huang D, Weng H, Zeng XT. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? Mil Med Res 2020; 7: 7.
17.
Tan J, Li P, Wang Q, Li Y, Li X, Zhao D, et al. Autologous menstrual blood-derived stromal cells transplantation for severe Asherman’s syndrome. Hum Reprod 2016; 31: 2723-2729.
18.
Zhao G, Cao Y, Zhu X, Tang X, Ding L, Sun H, et al. Transplantation of collagen scaffold with autologous bone marrow mononuclear cells promotes functional endometrium reconstruction beta downregulating Np63 expression in Asherman’s syndrome. Sci China Life Sci 2017; 60: 404-416.
19.
Cao Y, Sun H, Zhu H, Zhu X, Tang X, Yan G, et al. Allogeneic cell therapy using umbilical cord MSCs on collagen scaffolds for patients with recurrent uterine adhesion: a phase I clinical trial. Stem Cell Res Ther 2018; 9: 192.
20.
Ma H, Liu M, Li Y, Wang W, Yang K, Lu L, et al. Intrauterine transplantation of autologous menstrual blood stem cells increases endometrial thickness and pregnancy potential in patients with refractory intrauterine adhesion. J Obstet Gynaecol Res 2020; 46: 2347-2355.
21.
Zhang Y, Shi L, Lin X, Zhou F, Xin L, Xu W, et al. Unresponsive thin endometrium caused by Asherman syndrome treated with umbilical cord mesenchymal stem cells on collagen scaffolds: a pilot study. Stem Cell Res Ther 2021; 22: 420.
22.
Huang J, Li Q, Yuan X, Liu Q, Zhang W, Li P. Intrauterine infusion of clinically graded human umbilical cord-derived mesenchymal stem cells for the treatment of poor healing after uterine injury: a phase I clinical trial. Stem Cell Res Ther 2022; 13: 85.
23.
Singh N, Mohanty S, Seth T, Shankar M, Bhaskaran S, Dharmendra S, et al. Autologous stem cell transplantation in refractory Asherman’s syndrome: a novel cell based therapy. J Hum Reprod Sci 2014; 7: 93-98.
24.
Singh N, Shekhar B, Mohanty S, Kumar S, Seth T, Girish B. Autologous bone marrow-derived stem cell therapy for Asherman’s syndrome and endometrial atrophy: a 5-year follow-up study. J Hum Reprod Sci 2020; 13: 31-37.
25.
Patel Nayana H, Patel Nike H, Patel Molina N, Piyush C, Bhadarka HK, Rohan P, et al. Autologous bone marrow derived cell concentrate therapy for thin endometrium. J Regen Med 2021; 10: 6.
26.
Santamaria X, Cabanillas S, Cervelló I, Arbona C, Raga F, Ferro J, et al. Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractory Asherman’s syndrome and endometrial atrophy: a pilot cohort study. Hum Reprod 2016; 31: 1087-1096.
27.
Lee SY, Shin JE, Kwon H, Choi DH, Kim JH. Effect of autologous adipose-derived stromal vascular fraction transplantation on endometrial regeneration in patients of Asherman’s syndrome: a pilot study. Reprod Sci 2020; 27: 561-568.
28.
Arikan G, Turan V, Kurekeken M, Goksoy HS, Dogusan Z. Autologous bone marrow-derived nucleated cell (aBMNC) transplantation improves endometrial function in patients with refractory Asherman's syndrome or with thin and dysfunctional endometrium. J Assist Reprod Genet 2023; 40: 1163-1171.
29.
Di Guardo F, Della Corte L, Vilos GA, Carugno J, Török P, Giampaolino P, et al. Evaluation and treatment of infertile women with Asherman syndrome: an updated review focusing on the role of hysteroscopy. Reprod Biomed Online 2020; 41: 55-61.
30.
AAGL Elevating Gynecologic Surgery. AAGL practice report: practice guidelines on intrauterine adhesions developed in collaboration with the European Society of Gynaecological Endoscopy (ESGE). Gynecol. Surg 2017; 14: 6.
31.
Yang JH, Chen CD, Chen SU, Yang YS, Chen MJ. The influence of the location and extent of intrauterine adhesions on recurrence after hysteroscopic adhesiolysis. BJOG 2016; 123: 618-623.
32.
Verdi J, Tan A, Shoae-Hassani A, Seifalian AM. Endometrial stem cells in regenerative medicine. J Biol Eng 2014; 8: 20.
33.
Juan Cen, Yichen Zhang, Yindu Bai, Ma S, Zhang C, Jin L, et al. Research progress of stem cell therapy for endometrial injury. Materials Today Bio 2020; 16: 100389.
34.
Xu B, Cao Y, Zheng Z, Galan EA, Hu Z, Ge J, et al. Injectable mesenchymal stem cell-laden matrigel microspheres for endometrium repair and regeneration. Adv Biol (Weinh) 2021; 5: e2000202.
35.
Liu L, Huang X, Xia E, Zhang X, Li TC, Liu Y. A cohort study comparing 4 mg and 10 mg daily doses of postoperative oestradiol therapy to prevent adhesion reformation after hysteroscopic adhesiolysis. Hum Fertil 2019; 22: 191-197.
36.
Hanstede MMF, van Stralen KJ, Molkenboer JFM, Veersema S, Emanuel MH. Hormonal support in women with Asherman syndrome does not lead to better outcomes: a randomized trial. Reprod Med Biol 2023; 22: e12526.
